Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807325 · ClinicalTrials.gov registry record
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 72
- Enrollment target
NCT01807325: Completed study, sponsored by Oregon Health and Science University.
NCT01807325 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01807325 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy specimens from the pancreas that will give us a better test for diagnosis. This study is only for diagnosing these lesions. The investigators are not treating any patients.
Interventions
- PROCEDURE pancreas biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2012-12 |
| Est. Completion | 2019-12 |
What the finished NCT01807325 record still lists
NCT01807325 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which pancreas biopsy is the first listed.
NCT01807325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01807325 about?
NCT01807325 is a clinical study titled "RNA Sequencing of Solid and Cystic Lesions of the Pancreas". The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy ...
What is the current status of trial NCT01807325?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2012-12. Estimated completion is 2019-12.
What interventions are being tested in trial NCT01807325?
The interventions under investigation include: pancreas biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01807325?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia